These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36334767)

  • 1. More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics.
    Aqil M; Roseman L
    Neuropharmacology; 2023 Feb; 223():109300. PubMed ID: 36334767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic Psychedelic Drugs: Update on Biological Mechanisms.
    Vollenweider FX; Smallridge JW
    Pharmacopsychiatry; 2022 May; 55(3):121-138. PubMed ID: 35079988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An introduction to psychedelic neuroscience.
    Calvey T; Howells FM
    Prog Brain Res; 2018; 242():1-23. PubMed ID: 30471677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelics and Neural Plasticity: Therapeutic Implications.
    Grieco SF; Castrén E; Knudsen GM; Kwan AC; Olson DE; Zuo Y; Holmes TC; Xu X
    J Neurosci; 2022 Nov; 42(45):8439-8449. PubMed ID: 36351821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.
    Tófoli LF; de Araujo DB
    Int Rev Neurobiol; 2016; 129():157-85. PubMed ID: 27503452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenomenology, Structure, and Dynamic of Psychedelic States.
    Preller KH; Vollenweider FX
    Curr Top Behav Neurosci; 2018; 36():221-256. PubMed ID: 28025814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.
    Yaden DB; Johnson MW; Griffiths RR; Doss MK; Garcia-Romeu A; Nayak S; Gukasyan N; Mathur BN; Barrett FS
    Int J Neuropsychopharmacol; 2021 Aug; 24(8):615-623. PubMed ID: 33987652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The socialization of hallucinations: Cultural priors, social interactions, and contextual factors in the use of psychedelics.
    Dupuis D
    Transcult Psychiatry; 2022 Oct; 59(5):625-637. PubMed ID: 36367797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelics and music: neuroscience and therapeutic implications.
    Barrett FS; Preller KH; Kaelen M
    Int Rev Psychiatry; 2018 Aug; 30(4):350-362. PubMed ID: 30240282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renaissance in psychedelic research: What do preclinical models have to offer.
    Murnane KS
    Prog Brain Res; 2018; 242():25-67. PubMed ID: 30471682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.
    Moreton SG; Szalla L; Menzies RE; Arena AF
    Psychopharmacology (Berl); 2020 Jan; 237(1):21-32. PubMed ID: 31784805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of psychedelic drug action: modulation of cortical-subcortical circuits.
    Doss MK; Madden MB; Gaddis A; Nebel MB; Griffiths RR; Mathur BN; Barrett FS
    Brain; 2022 Apr; 145(2):441-456. PubMed ID: 34897383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural correlates of the LSD experience revealed by multimodal neuroimaging.
    Carhart-Harris RL; Muthukumaraswamy S; Roseman L; Kaelen M; Droog W; Murphy K; Tagliazucchi E; Schenberg EE; Nest T; Orban C; Leech R; Williams LT; Williams TM; Bolstridge M; Sessa B; McGonigle J; Sereno MI; Nichols D; Hellyer PJ; Hobden P; Evans J; Singh KD; Wise RG; Curran HV; Feilding A; Nutt DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4853-8. PubMed ID: 27071089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelics.
    Kelmendi B; Kaye AP; Pittenger C; Kwan AC
    Curr Biol; 2022 Jan; 32(2):R63-R67. PubMed ID: 35077687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelic drugs and perception: a narrative review of the first era of research.
    Aday JS; Wood JR; Bloesch EK; Davoli CC
    Rev Neurosci; 2021 Jul; 32(5):559-571. PubMed ID: 33550787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
    Vollenweider FX; Kometer M
    Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.